Sangamo BioSciences | SGMO - DEBITO





DEBITO Cambiamento Data
Alaunos Therapeutics USD 10.99M 5.78M 2023-03
Alnylam Pharmaceuticals USD 1.28B 30.06M 2025-12
Alterity Therapeutics Limited AUD 210.39K 120.67K 2023-06
Amgen USD 54.6B 17M 2025-12
Bayer EUR 36.45B 2.93B 2025-12
BioCryst Pharmaceuticals USD 828.6M 510K 2024-12
Biogen USD 6.56B 275.1M 2026-03
BioMarin Pharmaceutical USD 1.44B 833.74M 2026-03
Cipla INR 4.38B 231.9M 2025-03
Clal Biotechnology ILS 35.76M 28.27M 2023-12
Compugen USD 2.95M 24K 2025-09
CSL USD 11.96B 219M 2024-12
Gilead Sciences USD 24.94B 5M 2025-12
GlaxoSmithKline GBP 19.06B 1.34B 2026-03
Grifols EUR 9.23B 626.05M 2024-12
Ionis Pharmaceuticals USD 2.34B 9.5M 2026-03
J&J USD 47.93B 2.14B 2025-12
Karyopharm Therapeutics USD 299.23M 35.14M 2025-12
Merck USD 49.34B 7.97B 2025-12
Novartis USD 47B 11.62B 2026-03
Omeros USD 442.16M 199K 2023-09
Pfizer USD 63.73B 231M 2026-03
Roche Holding CHF 33.03B 1.41B 2025-06
Sangamo BioSciences USD 0 0 2022-06
Sanofi EUR 20.33B 1.43B 2025-12
Sarepta Therapeutics USD 1.04B 210.44M 2025-12
Tectonic Therapeutic USD 876K 115K 2024-12
Ultragenyx Pharmaceutical USD 36M 2.17M 2025-12
Vertex Pharmaceuticals USD 1.99B 44M 2026-03